• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心原性休克的临床特征和短期死亡率预测。

Clinical picture and risk prediction of short-term mortality in cardiogenic shock.

机构信息

Emergency Medicine, University of Helsinki, Helsinki University Hospital, Helsinki, Finland.

出版信息

Eur J Heart Fail. 2015 May;17(5):501-9. doi: 10.1002/ejhf.260. Epub 2015 Mar 28.

DOI:10.1002/ejhf.260
PMID:25820680
Abstract

AIMS

The aim of this study was to investigate the clinical picture and outcome of cardiogenic shock and to develop a risk prediction score for short-term mortality.

METHODS AND RESULTS

The CardShock study was a multicentre, prospective, observational study conducted between 2010 and 2012. Patients with either acute coronary syndrome (ACS) or non-ACS aetiologies were enrolled within 6 h from detection of cardiogenic shock defined as severe hypotension with clinical signs of hypoperfusion and/or serum lactate >2 mmol/L despite fluid resuscitation (n = 219, mean age 67, 74% men). Data on clinical presentation, management, and biochemical variables were compared between different aetiologies of shock. Systolic blood pressure was on average 78 mmHg (standard deviation 14 mmHg) and mean arterial pressure 57 (11) mmHg. The most common cause (81%) was ACS (68% ST-elevation myocardial infarction and 8% mechanical complications); 94% underwent coronary angiography, of which 89% PCI. Main non-ACS aetiologies were severe chronic heart failure and valvular causes. In-hospital mortality was 37% (n = 80). ACS aetiology, age, previous myocardial infarction, prior coronary artery bypass, confusion, low LVEF, and blood lactate levels were independently associated with increased mortality. The CardShock risk Score including these variables and estimated glomerular filtration rate predicted in-hospital mortality well (area under the curve 0.85).

CONCLUSION

Although most commonly due to ACS, other causes account for one-fifth of cases with shock. ACS is independently associated with in-hospital mortality. The CardShock risk Score, consisting of seven common variables, easily stratifies risk of short-term mortality. It might facilitate early decision-making in intensive care or guide patient selection in clinical trials.

TRIAL REGISTRATION

NCT01374867.

摘要

目的

本研究旨在探讨心原性休克的临床特征和转归,并建立短期死亡率的风险预测评分。

方法和结果

CardShock 研究是一项多中心、前瞻性、观察性研究,于 2010 年至 2012 年进行。在出现心原性休克后 6 小时内,患者被纳入研究,心原性休克的定义为严重低血压,伴有灌注不足的临床征象和/或血清乳酸>2mmol/L,尽管进行了液体复苏(n=219,平均年龄 67 岁,74%为男性)。比较不同病因休克患者的临床表现、治疗和生化变量。平均收缩压为 78mmHg(标准差 14mmHg),平均动脉压为 57(11)mmHg。最常见的病因(81%)是 ACS(68%ST 段抬高型心肌梗死和 8%机械并发症);94%的患者进行了冠状动脉造影,其中 89%进行了 PCI。主要的非 ACS 病因是严重的慢性心力衰竭和瓣膜性病因。院内死亡率为 37%(n=80)。ACS 病因、年龄、既往心肌梗死、既往冠状动脉旁路移植术、意识障碍、低左心室射血分数和血乳酸水平与死亡率增加独立相关。包括这些变量和估算肾小球滤过率的 CardShock 风险评分能很好地预测院内死亡率(曲线下面积 0.85)。

结论

尽管最常见的病因是 ACS,但其他病因占休克病例的五分之一。ACS 与院内死亡率独立相关。CardShock 风险评分由七个常见变量组成,可简单地分层短期死亡率风险。它可能有助于重症监护室的早期决策或指导临床试验中的患者选择。

试验注册

NCT01374867。

相似文献

1
Clinical picture and risk prediction of short-term mortality in cardiogenic shock.心原性休克的临床特征和短期死亡率预测。
Eur J Heart Fail. 2015 May;17(5):501-9. doi: 10.1002/ejhf.260. Epub 2015 Mar 28.
2
Altered mental status predicts mortality in cardiogenic shock - results from the CardShock study.意识状态改变预测心原性休克患者的死亡率——来自 CardShock 研究的结果。
Eur Heart J Acute Cardiovasc Care. 2018 Feb;7(1):38-44. doi: 10.1177/2048872617702505. Epub 2017 Apr 13.
3
Blood lactate is a predictor of short-term mortality in patients with myocardial infarction complicated by heart failure but without cardiogenic shock.血乳酸是心肌梗死合并心力衰竭但无心源性休克患者短期死亡率的预测指标。
BMC Cardiovasc Disord. 2018 Jan 18;18(1):8. doi: 10.1186/s12872-018-0744-1.
4
Combined Measurement of Soluble ST2 and Amino-Terminal Pro-B-Type Natriuretic Peptide Provides Early Assessment of Severity in Cardiogenic Shock Complicating Acute Coronary Syndrome.可溶性ST2与氨基末端前B型利钠肽联合检测可对急性冠状动脉综合征并发心源性休克的严重程度进行早期评估。
Crit Care Med. 2017 Jul;45(7):e666-e673. doi: 10.1097/CCM.0000000000002336.
5
Temporal trends in the epidemiology, management, and outcome of patients with cardiogenic shock complicating acute coronary syndromes.急性冠状动脉综合征并发心原性休克患者的流行病学、治疗方法和预后的时间趋势。
Eur J Heart Fail. 2015 Nov;17(11):1124-32. doi: 10.1002/ejhf.339. Epub 2015 Sep 4.
6
Outcomes of cardiogenic shock complicating acute coronary syndromes.急性冠状动脉综合征并发心源性休克的预后。
Catheter Cardiovasc Interv. 2020 Sep 1;96(3):E257-E267. doi: 10.1002/ccd.28759. Epub 2020 Feb 3.
7
The association of admission blood glucose level with the clinical picture and prognosis in cardiogenic shock - Results from the CardShock Study.入院血糖水平与心源性休克临床症状及预后的关联——心脏休克研究结果
Int J Cardiol. 2017 Jan 1;226:48-52. doi: 10.1016/j.ijcard.2016.10.033. Epub 2016 Oct 17.
8
Natural history and risk factors of long-term mortality in acute coronary syndrome patients with cardiogenic shock.急性冠脉综合征伴心原性休克患者长期死亡率的自然史和危险因素。
Adv Med Sci. 2014 Sep;59(2):156-60. doi: 10.1016/j.advms.2013.12.003. Epub 2014 Jun 9.
9
A simple risk chart for initial risk assessment of 30-day mortality in patients with cardiogenic shock from ST-elevation myocardial infarction.用于对ST段抬高型心肌梗死所致心源性休克患者30天死亡率进行初始风险评估的简易风险图表。
Eur Heart J Acute Cardiovasc Care. 2016 Apr;5(2):101-7. doi: 10.1177/2048872615568966. Epub 2015 Jan 14.
10
Risk Stratification for Patients in Cardiogenic Shock After Acute Myocardial Infarction.心肌梗死后心源性休克患者的风险分层。
J Am Coll Cardiol. 2017 Apr 18;69(15):1913-1920. doi: 10.1016/j.jacc.2017.02.027.

引用本文的文献

1
Systolic Blood Pressure and Microaxial Flow Pump-Associated Survival in Infarct-Related Cardiogenic Shock: A Post Hoc Analysis of the DanGer Shock Randomized Clinical Trial.收缩压与微轴流泵辅助梗死相关心源性休克患者生存率的关系:Danger Shock随机临床试验的事后分析
JAMA Cardiol. 2025 Aug 30. doi: 10.1001/jamacardio.2025.3337.
2
Cardiogenic shock: diagnosis, phenotyping and management.心源性休克:诊断、分型及管理
Intensive Care Med. 2025 Aug 6. doi: 10.1007/s00134-025-08049-y.
3
Targeting high circulating dipeptidyl peptidase 3 in circulatory failure.
针对循环衰竭中高循环水平的二肽基肽酶3
Crit Care. 2025 Jul 31;29(1):340. doi: 10.1186/s13054-025-05545-x.
4
Retrospective exploratory dual-center analysis of temporary transvenous cardiac pacing in cardiogenic shock.心源性休克中临时经静脉心脏起搏的回顾性探索性双中心分析
Sci Rep. 2025 Jul 19;15(1):26241. doi: 10.1038/s41598-025-10364-9.
5
Albumin-to-Globulin ratio as an independent risk factor for predicting prognostic risk in patients with acute coronary syndrome undergoing percutaneous coronary intervention.白蛋白与球蛋白比值作为预测接受经皮冠状动脉介入治疗的急性冠状动脉综合征患者预后风险的独立危险因素。
BMC Cardiovasc Disord. 2025 Jul 18;25(1):525. doi: 10.1186/s12872-025-04983-3.
6
Prognostic implication of venoarterial extracorporeal membrane oxygenation in acute myocardial infarction-related cardiogenic shock.静脉-动脉体外膜肺氧合在急性心肌梗死相关心源性休克中的预后意义
J Intensive Care. 2025 Jul 2;13(1):38. doi: 10.1186/s40560-025-00807-w.
7
Hemoglobin in cardiogenic shock: the lower, the poorer survival.心源性休克中的血红蛋白:水平越低,生存率越低。
J Intensive Care. 2025 Jun 23;13(1):36. doi: 10.1186/s40560-025-00805-y.
8
Influence of Hospital Ownership on Patient Outcomes in ST-Elevation Myocardial Infarction-Induced Cardiogenic Shock Undergoing Revascularization: A Retrospective Cohort Study.医院所有权对接受血运重建的ST段抬高型心肌梗死所致心源性休克患者预后的影响:一项回顾性队列研究
Cureus. 2025 May 20;17(5):e84471. doi: 10.7759/cureus.84471. eCollection 2025 May.
9
Initial Care Pathway in Acute Heart Failure From Home to Hospital.急性心力衰竭从家庭到医院的初始护理路径
Clin Cardiol. 2025 Jun;48(6):e70161. doi: 10.1002/clc.70161.
10
Prognostic value of baseline glucose levels for mortality in patients with cardiogenic shock: a systematic review and meta-analysis.心源性休克患者基线血糖水平对死亡率的预后价值:一项系统评价和荟萃分析
J Cardiothorac Surg. 2025 May 26;20(1):237. doi: 10.1186/s13019-025-03483-x.